Latest News about AMGN
Recent news which mentions AMGN
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs
February 26, 2024
From Benzinga
3 Biotech Stocks to Buy and Hold for the Next 10 Years
February 26, 2024
From Motley Fool
Amgen Options Trading: A Deep Dive into Market Sentiment
February 23, 2024
Tickers
AMGN
From Benzinga
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
February 22, 2024
From InvestorPlace
Tickers
AMGN
From Motley Fool
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
From InvestorPlace
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
February 14, 2024
From InvestorPlace
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
February 14, 2024
From Motley Fool
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
February 14, 2024
From Motley Fool
2 Unstoppable Stocks to Buy and Hold for 2024 and Beyond
February 08, 2024
From Motley Fool
Investors' Focus Around Amgen's Obesity Drug Data Shadows Better Than Expected Q4 Earnings
February 07, 2024
From Benzinga
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
February 07, 2024
From Benzinga
34% of the Dow Jones Industrial Average's Weighting Is Determined by Just 5 Stocks
February 07, 2024
From Motley Fool
From InvestorPlace
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
From Benzinga
US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
February 06, 2024
From Benzinga
Earnings Scheduled For February 6, 2024
February 06, 2024
From Benzinga
3 Fantastic Dow Stocks to Buy in February 2024
February 05, 2024
From InvestorPlace
NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?
February 05, 2024
From InvestorPlace
Weight Loss Drug's New Entrant: Amgen To Compete With Novo Nordisk, Eli Lilly, As Investigational Weight Loss Drug Shows Encouraging Early Data
February 05, 2024
Tickers
AMGN
From Benzinga
Amgen Options Trading: A Deep Dive into Market Sentiment
January 30, 2024
Tickers
AMGN
From Benzinga
Tickers
AMGN
From Motley Fool
Should You Buy the Dogs of the Dow in 2024?
January 27, 2024
From Motley Fool
P/E Ratio Insights for Amgen
January 26, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.